SIMUROSERTIB

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C17H19N5OS
Molecular Weight	341.431
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC1=NNC=C1C2=CC3=C(S2)C(=O)NC(=N3)[C@@H]4CC5CCN4CC5

InChI

InChIKey=XGVXKJKTISMIOW-ZDUSSCGKSA-N

InChI=1S/C17H19N5OS/c1-9-11(8-18-21-9)14-7-12-15(24-14)17(23)20-16(19-12)13-6-10-2-4-22(13)5-3-10/h7-8,10,13H,2-6H2,1H3,(H,18,21)(H,19,20,23)/t13-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C17H19N5OS
Molecular Weight	341.431
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Cell division cycle 7-related protein kinase 5 Target ID: CHEMBL5443 Sources: https://www.ncbi.nlm.nih.gov/pubmed/31131319	Inhibitor 8297		0.3 nM [IC50]

PubMed

Title	Date	PubMed
Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitor.	2019 May	31131319

Substance Class	Chemical Created by `admin` on `Sat Dec 16 17:19:36 GMT 2023` Edited by `admin` on `Sat Dec 16 17:19:36 GMT 2023`
Record UNII	LST350G3XU
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SIMUROSERTIB

Official Name

English

TAK-931

Code

English

SIMUROSERTIB [USAN]

Common Name

English

Simurosertib [WHO-DD]

Common Name

English

simurosertib [INN]

Common Name

English

THIENO(3,2-D)PYRIMIDIN-4(3H)-ONE, 2-(2S)-1-AZABICYCLO(2.2.2)OCT-2-YL-6-(3-METHYL-1H-PYRAZOL-4-YL)-

Systematic Name

English

2-((2S)-1-AZABICYCLO(2.2.2)OCT-2-YL)-6-(3-METHYL-1H-PYRAZOL-4-YL)THIENO(3,2-D)PYRIMIDIN-4(3H)-ONE

Systematic Name

English

Code System Code Type Description

FDA UNII

LST350G3XU